Downregulation of MMP-2 and MMP-9 expression induced by MPPa-PDT may enhance the therapeutic efficacy for breast cancer by restricting metastasis by upregulating cell apoptosis and necrosis. This evidence concerns the gene MMP2 and breast carcinoma.